Efficacy, Safety and Pharmacokinetics of Once-Daily Saquinavir Soft-Gelatin Capsule/Ritonavir in Antiretroviral-Naive, HIV-Infected Patients

CONTEXT: Once-daily HIV treatment regimens are being used in clinical practice with the objective of improving patient acceptance and adherence. OBJECTIVE: To evaluate the efficacy and safety of saquinavir-soft-gelatin capsule (SGC)/ritonavir combination (1600 mg/100 mg) vs efavirenz (600 mg) both o...

Descripción completa

Detalles Bibliográficos
Autores principales: Julio, Montaner SG, Schutz, Malte, Schwartz, Robert, Jayaweera, Dushyantha T, Burnside, Alfred F, Walmsley, Sharon, Saag, Michael S
Formato: Texto
Lenguaje:English
Publicado: The International AIDS Society 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766177/
http://dx.doi.org/10.1186/1758-2652-8-2-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766177/
http://dx.doi.org/10.1186/1758-2652-8-2-36

Ejemplares similares